NAS:IRTC (USA) Also trade in: Germany

iRhythm Technologies Inc

$ 81.8 -1 (-1.21%)
Volume: 226,499 Avg Vol (1m): 331,349
Market Cap $: 2.02 Bil Enterprise Value $: 2.00 Bil
P/E (TTM): 0.00 P/B: 40.30
Earnings Power Value 0
Net Current Asset Value 1.06
Tangible Book 2
Projected FCF 0
Median P/S Value 83.28
Graham Number 0
Peter Lynch Value 0
DCF (FCF Based) 0
DCF (Earnings Based) 0
1Y (-%)

Financial Strength : 6.2/10

GuruFocus Financial Strength Rank measures how strong a company's financial situation is . It is based on these factors
1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.
A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.
Current vs industry vs history
Cash-to-Debt 1.68
Cash-To-Debt range over the past 10 years
Min: 0.18, Med: 2.57, Max: 3.32
Current: 1.68
0.18
3.32
Equity-to-Asset 0.42
Equity-to-Asset range over the past 10 years
Min: -4.2, Med: 0.57, Max: 0.67
Current: 0.42
-4.2
0.67
Debt-to-Equity 0.70
Debt-to-Equity range over the past 10 years
Min: -2.96, Med: 0.39, Max: 0.7
Current: 0.7
-2.96
0.7
Debt-to-EBITDA -0.87
Debt-to-EBITDA range over the past 10 years
Min: -1.89, Med: -1.39, Max: -0.42
Current: -0.87
-1.89
-0.42
Piotroski F-Score 3
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 15.52
DISTRESS
GREY
SAFE
Beneish M-Score -1.41
Not Manipulator
Manipulator

Profitability & Growth : 3/10

GuruFocus Profitability Rank ranks how profitable a company is and how likely the company's business will stay that way.
Current vs industry vs history
Operating Margin % -24.98
Operating Margin range over the past 10 years
Min: -67.89, Med: -29.61, Max: -24.32
Current: -24.98
-67.89
-24.32
Net Margin % -27.56
Net Margin range over the past 10 years
Min: -72.79, Med: -32.78, Max: -27.56
Current: -27.56
-72.79
-27.56
ROE % -73.06
ROE range over the past 10 years
Min: -73.06, Med: -53.13, Max: -34.19
Current: -73.06
-73.06
-34.19
ROA % -37.71
ROA range over the past 10 years
Min: -85.54, Med: -38.19, Max: -21.69
Current: -37.71
-85.54
-21.69
ROC (Joel Greenblatt) % -349.26
ROC (Joel Greenblatt) range over the past 10 years
Min: -898.16, Med: -536.83, Max: -349.26
Current: -349.26
-898.16
-349.26
3-Year Total Revenue Growth Rate 59.70
3-Year Revenue Growth Rate range over the past 10 years
Min: 36.1, Med: 39.8, Max: 43.5
Current: 36.1
36.1
43.5
3-Year Total EBITDA Growth Rate -26.30
3-Year EBITDA Growth Rate range over the past 10 years
Min: -7.6, Med: -5.05, Max: -2.5
Current: -7.6
-7.6
-2.5
3-Year EPS w/o NRI Growth Rate -8.80
3-Year EPS w/o NRI Growth Rate range over the past 10 years
Min: 0, Med: -4.4, Max: -8.8
Current: -8.8
0
-8.8

» IRTC's 30-Y Financials

Financials (Next Earnings Date: 2019-07-31)

Guru Trades Click for details

» Details

Insider Trades

SEC Filings

Gurus Latest Trades with NAS:IRTC

» Interactive Chart

Peter Lynch Chart

Business Description

Industry Medical Instruments & Equipment » Medical Instruments & Equipment    NAICS : 339112    SIC : 3841
Compare ROCO:1565 SZSE:002414 SZSE:300061 XKLS:7153 FRA:PHH2 NAS:NXTM TSE:3593 TSE:7730 NAS:ATRI SZSE:300595 SZSE:300677 NYSE:GKOS NAS:OSUR LSE:AMS XMCE:FAE NAS:NVCR NAS:LMNX SZSE:002901 TSE:7732 TSE:7780
Traded in other countries I25.Germany
Address 650 Townsend Street, Suite 500, San Francisco, CA, USA, 94103
iRhythm Technologies Inc is a commercial-stage digital healthcare company redefining the way cardiac arrhythmias are clinically diagnosed by combining wearable biosensing technology with cloud-based data analytics and machine-learning capabilities. The company generates its revenue from third party payors and institutions.

Ratios

Current vs industry vs history
PB Ratio 40.30
PB Ratio range over the past 10 years
Min: 6.39, Med: 20.11, Max: 47.9
Current: 40.3
6.39
47.9
PS Ratio 12.06
PS Ratio range over the past 10 years
Min: 8.04, Med: 12.27, Max: 18.22
Current: 12.06
8.04
18.22
EV-to-EBIT -46.90
EV-to-EBIT range over the past 10 years
Min: -58.7, Med: -45.2, Max: -29.4
Current: -46.9
-58.7
-29.4
EV-to-EBITDA -49.67
EV-to-EBITDA range over the past 10 years
Min: -61.9, Med: -47.8, Max: -30.5
Current: -49.67
-61.9
-30.5
EV-to-Revenue 12.21
EV-to-Revenue range over the past 10 years
Min: 8.1, Med: 12.2, Max: 18.1
Current: 12.21
8.1
18.1
Current Ratio 3.27
Current Ratio range over the past 10 years
Min: 1.91, Med: 5.19, Max: 9.98
Current: 3.27
1.91
9.98
Quick Ratio 3.18
Quick Ratio range over the past 10 years
Min: 1.73, Med: 5.08, Max: 9.88
Current: 3.18
1.73
9.88
Days Inventory 19.10
Days Inventory range over the past 10 years
Min: 17.72, Med: 22.15, Max: 28.19
Current: 19.1
17.72
28.19
Days Sales Outstanding 62.90
Days Sales Outstanding range over the past 10 years
Min: 47.99, Med: 54.46, Max: 98.23
Current: 62.9
47.99
98.23
Days Payable 17.16
Days Payable range over the past 10 years
Min: 17.16, Med: 36.23, Max: 41.25
Current: 17.16
17.16
41.25

Dividend & Buy Back

Current vs industry vs history
3-Year Share Buyback Rate -17.90
3-Year Share Buyback Rate range over the past 10 years
Min: -17.9, Med: -17.2, Max: -16.5
Current: -17.9
-17.9
-16.5

Valuation & Return

Current vs industry vs history
Price-to-Tangible-Book 40.90
Price-to-Tangible-Book range over the past 10 years
Min: 7.24, Med: 18.67, Max: 41.75
Current: 40.9
7.24
41.75
Price-to-Median-PS-Value 0.98
Price-to-Median-PS-Value range over the past 10 years
Min: 0.72, Med: 0.97, Max: 1.35
Current: 0.98
0.72
1.35
Earnings Yield (Joel Greenblatt) % -2.15
Earnings Yield (Greenblatt) range over the past 10 years
Min: -3.4, Med: -2.2, Max: -1.7
Current: -2.15
-3.4
-1.7

More Statistics

Revenue (TTM) (Mil) $ 163.94
EPS (TTM) $ -1.88
Beta 0
Volatility % 51.78
52-Week Range $ 58.99 - 98.37
Shares Outstanding (Mil) 24.69

Analyst Estimate

Piotroski F-Score Details

Piotroski F-Score 3
Positive ROA N
Positive CFROA N
Higher ROA yoy N
CFROA > ROA Y
Lower Leverage yoy N
Higher Current Ratio yoy N
Less Shares Outstanding yoy N
Higher Gross Margin yoy Y
Higher Asset Turnover yoy Y